Literature DB >> 16006132

Organic synthesis in pursuit of immunology: large-scale synthesis of peracetylated GM2 glycosylamino acid for preparation of a multiantigenic prostate cancer vaccine.

Young Shin Cho1, Qian Wan, Samuel J Danishefsky.   

Abstract

We describe herein the stereo-controlled, large-scale synthesis of peracetylated GM2 glycosylamino acid. Key features of the synthesis include a newly modified [1+3] coupling reaction and an olefin cross-metathesis-hydrogenation sequence. The GM2 glycosylamino acid is now ready for incorporation into a hexavalent prostate cancer vaccine construct.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006132     DOI: 10.1016/j.bmc.2005.06.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  "Biologic" level structures through chemistry: A total synthesis of a unimolecular pentavalent MUCI glycopeptide construct.

Authors:  Dongjoo Lee; Samuel J Danishefsky
Journal:  Tetrahedron Lett       Date:  2009-05-13       Impact factor: 2.415

2.  Synthesis of Biotinylated Tumor-Associated Carbohydrate Antigens for Immunological Studies.

Authors:  Jianglong Zhu; Qian Wan; Samuel J Danishefsky
Journal:  Tetrahedron Lett       Date:  2009-02-11       Impact factor: 2.415

Review 3.  Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.

Authors:  Jianglong Zhu; J David Warren; Samuel J Danishefsky
Journal:  Expert Rev Vaccines       Date:  2009-10       Impact factor: 5.217

4.  Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.

Authors:  Zhaojun Yin; Steven Dulaney; Craig S McKay; Claire Baniel; Katarzyna Kaczanowska; Sherif Ramadan; M G Finn; Xuefei Huang
Journal:  Chembiochem       Date:  2015-12-04       Impact factor: 3.164

5.  Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine.

Authors:  Zhifang Zhou; Satadru S Mandal; Guochao Liao; Jiatong Guo; Zhongwu Guo
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.